Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Volume 68, Issue 5, Pages (May 2018)
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 42, Issue 1, Pages (January 2005)
NS5A inhibitors in the treatment of hepatitis C
Volume 69, Issue 4, Pages (October 2018)
J. Ambrosioni, A. Mamin, A. Hadengue, M. Bernimoulin, K. Samii, C
Immigration and viral hepatitis
Virological tools to diagnose and monitor hepatitis C virus infection
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 70, Issue 1, Pages (January 2019)
Volume 62, Issue 3, Pages (March 2015)
Management of cirrhosis due to chronic hepatitis C
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Volume 62, Issue 1, Pages (January 2015)
Severe Constipation Clinical Gastroenterology and Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 44, Issue 2, Pages (February 2006)
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Economics of chronic hepatitis B and hepatitis C
EASL Clinical Practice Guidelines on hepatitis E virus infection
Hepatology may have problems with putative surrogate outcome measures
Volume 67, Issue 5, Pages (November 2017)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 67, Issue 5, Pages (November 2017)
Volume 70, Issue 1, Pages (January 2019)
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
The impact of intestinal microflora on serum bilirubin levels
Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?  Lawrence.
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Chronic hepatitis B in children and adolescents
Volume 62, Issue 3, Pages (March 2015)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
Hepatitis E virus: Infection beyond the liver?
Scott K. Fung, Anna S.F. Lok  Clinical Gastroenterology and Hepatology 
Volume 70, Issue 5, Pages (May 2019)
Volume 62, Issue 5, Pages (May 2015)
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection  Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel  Journal of Hepatology  Volume 66, Issue 1, Pages 242-243 (January 2017) DOI: 10.1016/j.jhep.2016.09.014 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The clinical course of treatment with sofosbuvir and ribavirin of chronic hepatitis E in an immunocompromised patient. HEV-RNA, hepatitis E virus RNA; neg, negative. (This figure appears in colour on the web.) Journal of Hepatology 2017 66, 242-243DOI: (10.1016/j.jhep.2016.09.014) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.